BA Van Hout
BA Van Hout publishes mostly in Economics and Econometrics, Hematology and Surgery, on topics such as Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy and Venous Thromboembolism Diagnosis and Management.
- World rank
- #6,065,176 of 7,710,434 ranked researchers
- Rank in Netherlands
- #99,030 of 107,149
- Works
- 48
- Citations
- 91
- Citations per work
- 1.9
What does BA Van Hout research?
BA Van Hout's work is mostly in Medicine (21%), Economics, Econometrics and Finance (16%), Biochemistry, Genetics and Molecular Biology (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else2960.0%
- Health Sciences1021.1%
- Medicine1021.1%
- Social Sciences715.6%
- Life Sciences23.3%
- 1Economics and Econometrics16% of their works
- 2Hematology8% of their works
- 3Surgery6% of their works
- 4Cardiology and Cardiovascular Medicine4% of their works
- 5Infectious Diseases3% of their works
- 6Molecular Biology3% of their works
Research topics
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Venous Thromboembolism Diagnosis and Management
- Lipoproteins and Cardiovascular Health
- Pain Management and Placebo Effect
- Neurological Disorders and Treatments
- Nuclear and radioactivity studies
- Cardiovascular Disease and Adiposity
Which keywords describe BA Van Hout's research?
The keywords of their largest research topics: Cost-effectiveness Analysis, Quality of Life, Clinical Trials, Drug Development Costs, Generic Drugs, Antithrombotic Therapy, Cholesterol-lowering and Statins.
- Placebo
- Nuclear Fuel
- Epicardial Fat
- Cerebrolysin
- Statins
- Antithrombotic Therapy
- Drug Development Costs
- Quality of Life
- Cost-effectiveness Analysis
- Clinical Trials
- Generic Drugs
- Cholesterol-lowering
- Venous Thromboembolism
- Citicoline
- Nocebo
- Perivascular Adipose Tissue
- Radiation Protection
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 17 words, with their numbers
- Cost-effectiveness Analysis61 topic
- Quality of Life61 topic
- Clinical Trials52 topics
- Drug Development Costs41 topic
- Generic Drugs41 topic
- Antithrombotic Therapy31 topic
- Cholesterol-lowering31 topic
- Statins31 topic
- Venous Thromboembolism31 topic
- Cerebrolysin21 topic
- Citicoline21 topic
- Epicardial Fat21 topic
- Nocebo21 topic
- Nuclear Fuel21 topic
- Perivascular Adipose Tissue21 topic
- Placebo21 topic
- Radiation Protection21 topic
Where does BA Van Hout work?
BA Van Hout's main affiliation in the publication record is Pharmerit (Netherlands), Netherlands.
How many publications and citations does BA Van Hout have?
OpenAlex counts 48 works and 91 citations for BA Van Hout, an h-index of 5, ranking #6,065,176 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about BA Van Hout. Posts are plain text and can be reported.